Hannu Revitzer
Papers
1
Total Citations
18
H-Index
1
About
Hannu Revitzer is a leading figure in the advancement of boron neutron capture therapy (BNCT), a targeted form of radiation oncology. His key research focuses on the clinical translation of BNCT, particularly the transition from nuclear reactor-based neutron sources to compact proton accelerator-based systems. Revitzer’s most impactful contribution is his comprehensive review of the Finnish BNCT experience, which analyzed outcomes for 249 patients treated at Helsinki University Hospital between 1999 and 2012 using the FiR 1 reactor and l-BPA-F as a boron carrier. This work, cited 18 times, provides critical long-term data on efficacy and safety, helping to validate BNCT as a viable treatment for aggressive cancers. By documenting this pioneering clinical series, Revitzer has helped shape the global roadmap for BNCT, demonstrating how historical reactor-based results inform the design of next-generation accelerator facilities. His work bridges decades of clinical practice with emerging technologies, solidifying his role as a key translator of BNCT from experimental therapy to a practical, hospital-based treatment modality.
Research Focus
Key Achievements
Top Papers
- 1